About

Peter Schwartz leads the firm’s Finance practice and represents direct lenders, private equity firms and corporate borrowers in financing transactions.

He has over 25 years…

Peter Schwartz leads the firm’s Finance practice and represents direct lenders, private equity firms and corporate borrowers in financing transactions.

He has over 25 years of experience structuring and negotiating debt financings. He also has extensive experience in M&A, private equity and venture capital, enabling him to provide clients with a broad perspective on their finance transactions.

Peter’s work covers a wide range of financial products, including senior secured, second lien and convertible loans, mezzanine debt, subordinated notes, preferred stock, and equity kickers. In addition to working on the origination of loans, he advises on debt restructurings and work-outs, forbearance arrangements, and public and private debt-for-equity exchanges.

He has worked on financings in a number of industries, including life sciences, healthcare, technology, consumer products and manufacturing. The life sciences work also includes the monetization of pharmaceutical royalty streams, which can be structured as financing or sale transactions.

About

Peter Schwartz leads the firm’s Finance practice and represents direct lenders, private equity firms and corporate borrowers in financing transactions.

He has over 25 years…

Peter Schwartz leads the firm’s Finance practice and represents direct lenders, private equity firms and corporate borrowers in financing transactions.

He has over 25 years of experience structuring and negotiating debt financings. He also has extensive experience in M&A, private equity and venture capital, enabling him to provide clients with a broad perspective on their finance transactions.

Peter’s work covers a wide range of financial products, including senior secured, second lien and convertible loans, mezzanine debt, subordinated notes, preferred stock, and equity kickers. In addition to working on the origination of loans, he advises on debt restructurings and work-outs, forbearance arrangements, and public and private debt-for-equity exchanges.

He has worked on financings in a number of industries, including life sciences, healthcare, technology, consumer products and manufacturing. The life sciences work also includes the monetization of pharmaceutical royalty streams, which can be structured as financing or sale transactions.

Subscribe: Subscribe via RSS